Feltl & Co.

Feltl & Co. upgraded Titan Machinery Inc. (NASDAQ: TITN) from Buy to Strong Buy. The price target for Titan Machinery has been raised to $20.50. Titan Machinery shares have dropped 20.05 percent over the past 52 weeks, while the S&P 500 index has surged 10.46 percent in the same period....

Feltl and Company downgraded xG Technology Inc (NASDAQ: XGTI) Monday from Hold to Sell and cut its price target from $1.00 to $0.35. Analyst Jeffrey A. Schreiner believed “XGTI’s backlog is the majority of its current stock valuation" and he saw a risk "that XGTI valuation...

Feltl and Company initiated coverage on Joint Corp (NASDAQ: JYNT) Friday with a Strong Buy rating and $12.45 price target. Analyst Brent R. Rystrom felt that “The Joint is poised to further disrupt the chiropractic industry. For the past few years JYNT has been growing rapidly as it...

Feltl and Company upgraded TearLab Corp (NASDAQ: TEAR) from Buy to Strong Buy Thursday and lowered its price target from $6.25 to $5. Analysts Ben C. Haynor and Ryan J. Thimjon believed “TearLab to be a unique medical technology company. There are few medical technology firms targeting a...

Feltl and Company reiterated its Buy rating and raised its price target Wednesday on Papa John’s Int'l, Inc. (NASDAQ: PZZA) from $51 to $54. The price target change comes after the company reported higher-than-expected sales and EPS of $0.39, beating the consensus of $0.37. Analyst...

According to a research report this morning, Feltl and Company reduces PT on Callidus Software (NASDAQ: CALD) to $8 due to negative backlash following a poor execution of Q1. Feltl and Company continued, “Our analysis of Callidus historical one-year forward valuation multiples (revenue, EPS)...

Feltl and Company reiterated its IDEXX Laboratories (NASDAQ: IDXX) Hold rating and increased its price target from $87.50 to $90 in a research report published today. In the report, Feltl and Company stated, "While we believe IDEXX is positioned well for veterinary market recovery, it currently...

In a research report published this morning by Feltl & Company, Saba Software's (NASDAQ: SABA) billings remain impressive. According to Feltl, “Saba reports preliminary 3Q12 results; SaaS billings remain impressive. Saba reported preliminary components to its 3Q12 results. Full 3Q12 results...

According to a research report published today, Feltl and Company is raising its estimates on Buffalo Wild Wings Inc. (NASDAQ: BWLD) for higher same-store sales. Feltl and Company commented in the report, “We are raising our 2012 revenue estimates for the strong 1Q:12 same-store sales and...

Feltl & Company has upgraded DexCom (NASDAQ: DXCM) from Hold to Buy and has lowered the price target from $15.85 to $15.35.

Feltl has downgraded Epicor Software (NASDAQ: EPIC) from Buy to Hold as the company is being acquired by Apex Partners for $12.50/share, according to Feltl & Company.

Despite being downgraded by Feltl & Co. on Wednesday, Zebra Technologies Corporation (Nasdaq: ZBRA) stock rose another 2%. Feltl & Co. also lowered its price target for the stock from $31 to $29. Feltl & Co's downgrade of the manufacturer and marketer of specialty printing devices was...